人凝血因子治疗血友病的论文
人凝血因子治疗血友病的论文
摘要:
血友病是一种常见的遗传性疾病,主要表现为凝血因子缺乏或异常,导致出血倾向。人凝血因子治疗是目前血友病的主要治疗方法。本文回顾了人凝血因子治疗血友病的历史、现状和未来发展趋势。同时,对人凝血因子治疗血友病的药物种类、剂量、给药途径、不良反应等进行了详细介绍,并对其优缺点进行了分析和讨论。
关键词:血友病;人凝血因子;治疗;药物
Abstract:
Hemophilia is a common genetic disease, mainly manifested as a lack or abnormality of coagulation factors, leading to bleeding tendency. Human coagulation factor therapy is currently the main treatment for hemophilia. This article reviews the history, current situation and future development trends of human coagulation factor therapy for hemophilia. At the same time, the types of drugs, doses, routes of administration, adverse reactions and other aspects of human coagulation factor therapy for hemophilia are introduced in detail, and its advantages and disadvantages are analyzed and discussed.
Keywords: hemophilia; human coagulation factor; treatment; drug
原文地址: https://www.cveoy.top/t/topic/bDgV 著作权归作者所有。请勿转载和采集!